Zeiss Medical Technology has received CE mark approval for its CIRRUS PathFinder, a clinical support tool that utilises AI to assist in the interpretation of optical coherence tomography (OCT) scans.

This tool aims to enhance decision-making processes and streamline workflows for clinicians.

The CIRRUS PathFinder employs deep learning algorithms to detect abnormal macular OCT B-scans automatically.